Matches in SemOpenAlex for { <https://semopenalex.org/work/W158605071> ?p ?o ?g. }
- W158605071 endingPage "365" @default.
- W158605071 startingPage "349" @default.
- W158605071 abstract "Background: A number of different inhaler devices are available to deliver β2-adrenoceptor agonist (β2-agonist) bronchodilators in asthma. These include hydrofluoroalkane or chlorofluorocarbon (CFC)-free propelled pressurized metered-dose inhalers (pMDIs), many dry powder inhalers and breath-actuated inhalers. Objective: To determine the clinical efficacy of all available hand-held inhaler devices compared with the standard CFC-containing pMDI for the delivery of short-acting β2-agonist bronchodilators in nonacute asthma in both children and adults. Methodology: A systematic review and meta-analysis was carried out of all available randomized, controlled trials (RCTs) using the standard pMDI compared with any other hand-held inhaler device, delivering short-acting β2-agonist bronchodilators in patients with stable asthma. Results: One hundred and eighteen RCTs were included in this review. No clinical differences were found between the standard CFC-containing pMDI and 12 other hand-held inhaler devices for most outcome measures. We found no evidence of clinical differences between studies using either a 1 : 1 (pMDI: another inhaler) or a 2 : 1 dosing ratio. Conclusions: In patients with stable asthma, short-acting β2-agonist bronchodilators in standard CFC-pMDIs are as effective as any other hand-held inhaler device; therefore the cheapest available device that the patient is able to use should always be considered. Pharmaceutical companies should in future submit to regulatory authorities clinical outcome data (as opposed to in vitro data) in support of any dosing schedules greater than 1 : 1 when compared with the standard pMDI. Clinical effectiveness studies that use an intention-to-treat analysis and report more patient-centered outcomes are required." @default.
- W158605071 created "2016-06-24" @default.
- W158605071 creator A5027261805 @default.
- W158605071 date "2003-08-01" @default.
- W158605071 modified "2023-10-18" @default.
- W158605071 title "Clinical Efficacy of Inhaler Devices Containing β2-Agonist Bronchodilators in the Treatment of Asthma" @default.
- W158605071 cites W1930420926 @default.
- W158605071 cites W1960501129 @default.
- W158605071 cites W1964130984 @default.
- W158605071 cites W1966971246 @default.
- W158605071 cites W1968744941 @default.
- W158605071 cites W1971649719 @default.
- W158605071 cites W1974926218 @default.
- W158605071 cites W1978058546 @default.
- W158605071 cites W1983366056 @default.
- W158605071 cites W1985793380 @default.
- W158605071 cites W1986215651 @default.
- W158605071 cites W1996673968 @default.
- W158605071 cites W1997714252 @default.
- W158605071 cites W2002233703 @default.
- W158605071 cites W2006339508 @default.
- W158605071 cites W2008742573 @default.
- W158605071 cites W2010383119 @default.
- W158605071 cites W201680056 @default.
- W158605071 cites W2017460037 @default.
- W158605071 cites W2019369912 @default.
- W158605071 cites W2025076054 @default.
- W158605071 cites W2028303068 @default.
- W158605071 cites W2029823532 @default.
- W158605071 cites W2033700556 @default.
- W158605071 cites W2033974980 @default.
- W158605071 cites W2037482269 @default.
- W158605071 cites W2037936952 @default.
- W158605071 cites W2044350271 @default.
- W158605071 cites W2048550942 @default.
- W158605071 cites W2049120461 @default.
- W158605071 cites W2053609335 @default.
- W158605071 cites W2053683295 @default.
- W158605071 cites W2054395062 @default.
- W158605071 cites W2055339903 @default.
- W158605071 cites W2056173251 @default.
- W158605071 cites W2056824888 @default.
- W158605071 cites W2061245276 @default.
- W158605071 cites W2063689240 @default.
- W158605071 cites W2065174142 @default.
- W158605071 cites W2068959999 @default.
- W158605071 cites W2069091142 @default.
- W158605071 cites W2070726071 @default.
- W158605071 cites W2070892323 @default.
- W158605071 cites W2071230213 @default.
- W158605071 cites W2073370777 @default.
- W158605071 cites W2074160997 @default.
- W158605071 cites W2074837785 @default.
- W158605071 cites W2074935944 @default.
- W158605071 cites W2078501542 @default.
- W158605071 cites W2079586195 @default.
- W158605071 cites W2079918231 @default.
- W158605071 cites W2081177753 @default.
- W158605071 cites W2083811676 @default.
- W158605071 cites W2083878481 @default.
- W158605071 cites W2087409254 @default.
- W158605071 cites W2090132433 @default.
- W158605071 cites W2091041889 @default.
- W158605071 cites W2092724975 @default.
- W158605071 cites W2092746741 @default.
- W158605071 cites W2095428109 @default.
- W158605071 cites W2095548954 @default.
- W158605071 cites W2106508230 @default.
- W158605071 cites W2107462455 @default.
- W158605071 cites W2112718944 @default.
- W158605071 cites W2125840821 @default.
- W158605071 cites W2130562482 @default.
- W158605071 cites W2130876329 @default.
- W158605071 cites W2131145070 @default.
- W158605071 cites W2133384313 @default.
- W158605071 cites W2133505989 @default.
- W158605071 cites W2134391509 @default.
- W158605071 cites W2136993432 @default.
- W158605071 cites W2140730458 @default.
- W158605071 cites W2141697273 @default.
- W158605071 cites W2141784101 @default.
- W158605071 cites W2143335419 @default.
- W158605071 cites W2147862540 @default.
- W158605071 cites W2149164014 @default.
- W158605071 cites W2149674096 @default.
- W158605071 cites W2154624669 @default.
- W158605071 cites W2155259186 @default.
- W158605071 cites W2157823046 @default.
- W158605071 cites W2158312773 @default.
- W158605071 cites W2160654785 @default.
- W158605071 cites W2169732843 @default.
- W158605071 cites W2170352416 @default.
- W158605071 cites W2170805842 @default.
- W158605071 cites W2170998774 @default.
- W158605071 cites W2204546955 @default.
- W158605071 cites W4233954896 @default.
- W158605071 cites W4240836031 @default.
- W158605071 cites W87132012 @default.